NCT01007448 2019-11-12Study Evaluating Two Dose Levels of Targretin Capsules in Participants With Refractory Cutaneous T-Cell Lymphoma (CTCL)Bausch Health Americas, Inc.Phase 4 Completed59 enrolled 17 charts
NCT00050999 2008-03-05Study of ONTAK (Denileukin Diftitox) in Cutaneous T-Cell Lymphoma (CTCL) PatientsEisai Inc.Phase 4 Completed195 enrolled
NCT00051012 2008-03-05Study of ONTAK (Denileukin Diftitox) in Previously Treated Cutaneous T-Cell Lymphoma PatientsEisai Inc.Phase 4 Completed86 enrolled